Readnour Robin Shane

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$1.64M
Insider Sells Quantity
2
Insider Sells Sum
$111,671.98

Insider Activity of Readnour Robin Shane

According to the SEC Form 4 filings, Readnour Robin Shane, being in a position of

  1. director at AN2 Therapeutics, Inc.,
    оver the last 12 months, has bought 335000 shares for $405,521, and sold 5094 shares for $111,672,
    over all time since 2022-03-29, has bought 417618 shares for $1.64M, and sold 5094 shares for $111,672.

The largest purchase of all time was on 2022-03-29 and amounted to 82618 shares of AN2 Therapeutics, Inc. for $1.24M.

The largest sale of all time was on 2024-01-10 and amounted to 3669 shares of AN2 Therapeutics, Inc. for $80,443.

Biography of Readnour Robin Shane

No biography is available at this moment.

2024-12-10PurchaseAN2 Therapeutics, Inc.
ANTX
director
10,000
0.0329%
$1.49$14,930-7.95%
2024-12-09PurchaseAN2 Therapeutics, Inc.
ANTX
director
30,772
0.104%
$1.43$43,984+0.7%
2024-12-06PurchaseAN2 Therapeutics, Inc.
ANTX
director
19,228
0.0635%
$1.45$27,795-1.04%
2024-11-27PurchaseAN2 Therapeutics, Inc.
ANTX
director
50,000
0.142%
$1.42$70,840+6.93%
2024-11-26PurchaseAN2 Therapeutics, Inc.
ANTX
director
25,000
0.0698%
$1.39$34,845+4.32%
2024-11-20PurchaseAN2 Therapeutics, Inc.
ANTX
director
50,000
0.116%
$1.16$57,870+10%
2024-11-19PurchaseAN2 Therapeutics, Inc.
ANTX
director
150,000
0.3112%
$1.04$155,258+34.43%
2024-01-12SaleAN2 Therapeutics, Inc.
ANTX
director
1,425
0.0626%
$21.91$31,229-89.7%
2024-01-10SaleAN2 Therapeutics, Inc.
ANTX
director
3,669
0.1612%
$21.93$80,443-89.61%
2022-03-29PurchaseAN2 Therapeutics, Inc.
ANTX
82,618
2.4836%
$15.00$1.24M-24.72%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.